Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors.
You-Cheng ZhangTian-Chen ZhuRun-Cong NieLiang-He LuZhi-Cheng XiangDan XieRong-Zhen LuoMu-Yan CaiPublished in: Journal of clinical medicine (2023)
Early irAEs, especially cutaneous irAEs, correlated with a better clinical outcome in patients treated with ICIs.
Keyphrases